30 April 2014: orphan reach, the first global patient centric CRO dedicated to orphan drug research, is proud to announce the release of their new website. The last […]
orphan reach, the “rare” Contract Research Organization (CRO) focusing on global orphan drug development, has today announced the opening of new offices in New Jersey, USA […]
We are delighted to be exhibiting at World Orphan Drug Congress, Barcelona in less than two weeks’ time. The conference agenda covers the strategic and commercial […]
Orphan Reach today confirmed that they have been acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. […]
There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.
Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.